Nanopharmaceuticals : expectations and realities of multifunctional drug delivery systems. Volume 1 /
Clasificación: | Libro Electrónico |
---|---|
Otros Autores: | |
Formato: | Electrónico eBook |
Idioma: | Inglés |
Publicado: |
Amsterdam :
Elsevier,
2020.
|
Temas: | |
Acceso en línea: | Texto completo |
Tabla de Contenidos:
- Front Cover
- NANOPHARMACEUTICALS
- NANOPHARMACEUTICALS
- Copyright
- Contents
- Contributors
- Preface
- 1
- Solid lipid nanoparticles (SLN): prediction of toxicity, metabolism, fate and physicochemical properties
- 1. Introduction
- 2. Toxicity profiling
- 3. Physicochemical properties
- 3.1 Encapsulation parameters
- 3.2 Particle size
- 3.3 Zeta potential
- 3.4 Particle morphology
- 3.5 Differential scanning calorimetry
- 3.6 Stability of formulations and release profile
- 4. Administration routes and drug bioavailability
- 4.1 Topical and dermal routes
- 4.2 Ocular delivery
- 4.3 Oral administration
- 4.4 Parenteral administration
- 4.5 Nasal and pulmonary delivery
- 5. Conclusions
- Abbreviations
- Acknowledgments
- References
- 2
- Role of nanocarriers and their surface modification in targeting delivery of bioactive compounds
- 1. Bioactive compounds as promising therapeutic agents
- 1.1 Curcuma sp
- 1.2 Zingiber officinale
- 1.3 Silybum marianum L
- 1.4 Gnetum gnemon
- 1.5 Physalis angulata
- 2. Complexity of bioactive compounds
- 3. Biological barriers
- 3.1 Physical barriers
- 3.2 Biochemical barriers
- 4. Nanocarrier: a strategy to overcome biological barriers
- 4.1 Lipid-based nanocarrier systems
- 4.1.1 Liposomes
- 4.1.2 Nanoemulsions
- 4.1.3 Solid lipid nanoparticles
- 5. Safe-by-design bioactive-loaded nanocarrier system development
- 6. Cellular uptake capability of bioactive-loaded nanocarrier system
- 7. Surface modification of nanocarriers
- 8. Biokinetic profile of bioactive-loaded nanocarriers
- 9. Challenges of bioactive-loaded nanocarrier to clinical translation
- 9.1 Patents on herbal nanoparticles for breast cancer
- 10. Conclusion
- References
- 3
- Polymeric nanomicelles as versatile tool for multidrug delivery in chemotherapy
- 1. Introduction
- 2. Micelles, principles and characterization
- 2.1 Preparation methods
- 2.2 Characterization techniques
- 2.3 Drug-loading methods
- 3. Polymeric micelles for codelivery of chemotherapeutics
- 3.1 Codelivery of chemotherapeutics to overcome multidrug resistance
- 3.1.1 Codelivery of chemotherapeutics and chemosensitizers
- 3.1.2 Codelivery of chemotherapeutics and downregulating gene agents
- 3.2 Codelivery of chemotherapeutics to achieve synergistic effects by methods other than effects on MDR
- 3.3 Codelivery of chemotherapeutics to mitigate side effects
- 4. Stimuli-responsive codelivery of polymeric micelles
- 4.1 pH-sensitive codelivery systems
- 4.2 Redox-sensitive codelivery systems
- 5. Targeted codelivery of polymeric micelles
- 6. Application of polymeric micelles in codelivery for multiple therapies
- 6.1 Chemo-immunotherapy
- 6.2 Chemo-angiogenic therapy
- 6.3 Chemo-photothermal therapy
- 6.4 Chemo-radiotherapy
- 6.5 Chemo-enzyme prodrug therapy